Market revenue in 2023 | USD 1,316.0 million |
Market revenue in 2030 | USD 2,476.9 million |
Growth rate | 9.5% (CAGR from 2023 to 2030) |
Largest segment | Next generation sequencing |
Fastest growing segment | Next Generation Sequencing |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Next Generation Sequencing, QPCR & Multiplexing, LOAC & RT-PCR, Protein Microarrays, DNA Microarrays |
Key market players worldwide | Johnson & Johnson, Illumina Inc, Novartis AG ADR, Roche, Koninklijke Philips NV, Qiagen NV, Agilent Technologies Inc, Abbott Laboratories, Thermo Fisher Scientific Inc, GE HealthCare Technologies Inc Common Stock |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to next generation cancer diagnostics market will help companies and investors design strategic landscapes.
Next generation sequencing was the largest segment with a revenue share of 36.85% in 2023. Horizon Databook has segmented the Latin America next generation cancer diagnostics market based on next generation sequencing, qpcr & multiplexing, loac & rt-pcr, protein microarrays, dna microarrays covering the revenue growth of each sub-segment from 2018 to 2030.
Although the incidence rates in this region are expected to be lower than the U.S. and Europe, the mortality rate is almost twice. Studies reveal that in Latin America, the major causes of mortality are prostate cancer followed by lung, stomach, and colorectal cancer in men, and breast cancer, stomach cancer, cervical, and lung cancer in women.
However, slow growth of primary care providers and insufficient infrastructure are the barriers that impede the ability of many Latin Americans to access timely and optimal cancer diagnosis.
Constant efforts are being taken to overcome these issues, which are expected to drive the market during the forecast period. Biomarker discovery has gained significant importance herein.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America next generation cancer diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America next generation cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account